A comparative study of pre-operative procedures to assess cervical invasion by endometrial carcinoma

BJOG: An International Journal of Obstetrics and Gynaecology

Volumn 105, Issue 5, 1998, Pages 512-516

  Toki, Toshihiko ^a   Oka, Kenji ^a   Nakayama, Kuniaki ^a   Oguchi, Osamu ^a   Fujii, Shingo ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CA 125 ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER INVASION; CANCER STAGING; CURETTAGE; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; ENDOMETRIUM CARCINOMA; FEMALE; HUMAN; HYSTEROSCOPY; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; NUCLEAR MAGNETIC RESONANCE IMAGING; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; TRANSVAGINAL ECHOGRAPHY; UTERINE CERVIX; UTERINE CERVIX CYTOLOGY;

ADULT; AGED; CA-125 ANTIGEN; DILATATION AND CURETTAGE; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; HYSTEROSCOPY; MAGNETIC RESONANCE IMAGING; MIDDLE AGED; NEOPLASM INVASIVENESS; PREOPERATIVE CARE; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 0031866081     PISSN: 14700328     EISSN: 14710528     Source Type: Journal    
DOI: 10.1111/j.1471-0528.1998.tb10151.x     Document Type: Article

References (23)

1. Heyman J, Reuterwell O, Brenner S. The radiumbemmet experience with radiotherapy in cancer of the corpus of the uterus. Acta Radiol 1941; 22: 14–98.
2. Berman ML, Ballon SC, Lagasse LD, Watring WG. Prognosis and treatment of endometrial cancer. Am J Obstet Gynecol 1980; 136: 679–688.
3. Leminen A, Forss M, Lehtovirta P. Endometrial adenocarcinoma with clinical evidence of cervical involvement: accuracy of diagnostic procedures, clinical course, and prognostic factors. Acta Obstet Gynecol Scand 1995; 74: 61–66.
4. Morrow CP, DiSaia PJ, Townsend DE. Current management of endometrial carcinoma. Obstet Gynecol 1973; 42: 399–406.
5. Boronow RC, Morrow CP, Creasman WT, DiSaia PJ, Silverberg SG, Miller A, Blessing JA. Surgical staging in endometrial cancer: clinicalpathologic findings of a prospective study. Obstet Gynecol 1984; 63: 825–832.
6. Kadar N, Malfetano JH, Homesley HD. Determinants of survival of surgically staged patients with endometrial carcinoma histologically confined to the uterus: implications for therapy. Obstet Gynecol 1992; 80: 655–659.
7. Boente MP, Yordan EL Jr, McIntosh DG et al. Prognostic factors and long-term survival in endometrial adenocarcinoma with cervical involvement. Gynecol Oncol 1993; 51: 316–322.
8. Weiner J, Bigelow B, Demopoulos RI, Beckman EM, Weiner I. The value of endocervical sampling in the staging of endometrial carcinoma. Diagn Gynecol Obstet 1980; 2: 265–268.
9. Bigelow B, Vekshtein V, Demopoulos RI. Endometrial carcinoma, Stage II: route and extent of spread to the cervix. Obsrer Gynecol 1983; 62: 363–366.
10. Chen SS, Lee L. Reappraisal of endocervical curettage in predicting cervical involvement by endometrial carcinoma. J Reprod Med 1986; 31: 50–52.
11. Taddei GL, Moncini D, Scarselli G, Tantini C, Bargelli G. Can hysteroscopic evaluation of endometrial carcinoma influence therapeutic treatment Ann N Y Acad Sci 1994; 734: 482–487.
12. Belloni C, Vigano R, del Maschio A, Sironi S, Taccagni GL, Vignali M. Magnetic resonance imaging in endometrial carcinoma staging. Gynecol Oncol 1990; 37: 172–177.
13. Hricak H, Rubinstein LV, Gherman GM, Karstaedt N. MR imaeine Y evaluation of endometrial carcinoma: results of an NCI cooperative study. Radiology 1991; 179: 829–832.
14. Murakami T, Kurachi H, Nakamura H et al. Cervical invasion of endometrial carcinoma: evaluation by parasagittal MR imaging. Acta Radiol 1995; 36: 248–253.
15. Artner A, Bosze P, Gonda G. The value of ultrasound in preoperative assessment of the myometrial and cervical invasion in endometrial carcinoma. Gynecol Oncol 1994; 54: 147–151.
16. Patsner B, Mann WJ, Cohen H, Loesch M. Predictive value of preoperative serum CA125 levels in clinically localized and advanced endometrial carcinoma. Am J Obstet Gynecol 1988; 158: 399–402.
17. Collins JA. Male infertility: the interpretation of the diagnostic assessment. In: Mishell DR, Paulsen CA, Lobo RA, editors. Yearbook of Infertility 1989. Chicago: Yearbook Medical Publishers, 1989: 45–75.
18. Larson DM, Johnson KK, Reyes CJ, Broste SK. Prognostic significance of malignant cervical cytology in patients with endometrial cancer. Obstet Gynecol 1994; 84: 399–403.
19. Surwit EA, Fowler WCJr, Rogoff EE. Stage II carcinoma of the endometrium. An analysis of treatment. Obstet Gynecol 1978; 52: 97–99.
20. Creasman WT, Morrow CP, Bundy BN, Homesley HD, Graham JE, Heller PB. Surgical pathologic spread patterns of endometrial cancer. A gynecologic oncology group study. Cancer 1987; 60: 2035–2041.
21. Hamlin DJ, Burgener FA, Beecham JB. CT of intramural endometrial carcinoma: contrast enhancement is essential. AJR 1981; 137: 551–554.
22. Bragg DG, Hricak H. Imaging in gynecologic malignancies. Cancer 1993; 71: 1648–1651.
23. Yamashita Y, Mizutani H, Torashima M et al. Assessment of myometrial invasion by endometrial carcinoma: transvaginal sonography vs contrast-enhanced MR imaging. AJR 1993; 161: 595–599.